| Literature DB >> 22661768 |
Paul A Wender1, Brian A Loy, Adam J Schrier.
Abstract
We review in part our computational, design, synthesis, and biological studies on a remarkable class of compounds and their designed analogs that have led to preclinical candidates for the treatment of cancer, a first-in-class approach to Alzheimer's disease, and a promising strategy to eradicate HIV/AIDS. Because these leads target, in part, protein kinase C (PKC) isozymes, they have therapeutic potential even beyond this striking set of therapeutic indications. This program has given rise to new synthetic methodology and represents an increasingly important direction of synthesis focused on achieving function through synthesis-informed design (function-oriented synthesis).Entities:
Year: 2011 PMID: 22661768 PMCID: PMC3364006 DOI: 10.1002/ijch.201100020
Source DB: PubMed Journal: Isr J Chem ISSN: 0021-2148 Impact factor: 3.333